Viewing Study NCT06231368

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:27 PM
Ignite Modification Date: 2026-01-04 @ 9:34 AM
Study NCT ID: NCT06231368
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-05-16
First Post: 2024-01-22
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: CNCT19 for Patients With Autoimmune Hemolytic Anemia After Failure ≥3 Lines of Therapy.
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Autoimmune Hemolytic Anemia View
None Autologous CD19 CAR-T View
None Failure of Three or More Lines of Therapy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Autoimmune Hemolytic Anemia View
None CNCT19 CAR T-Cell therapy View